EHMT2 and diffuse large B-cell lymphoma: The EHMT2 inhibitor triggered the inhibition of human diffuse large B-cell lymphoma cell proliferation leading to G1 phase arrest and induced apoptosis via endogenous and exogenous apoptotic pathways (Xu et al., 2021).